//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
10,833.954.6
Stock Analysis, IPO, Mutual Funds, Bonds & More

Dr. Reddy's Laboratories Ltd.

ET 500

Rank 2018
106
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    10:09 | 26-08-2019
  • BSE
    10:11 | 26-08-2019
2549.95

Today's Change

8.70 (0.34%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

108,757

Open

2559.95

Prev. Close

2541.25

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)5.00
  • EPS-TTM (Rs.)90.09
  • BV/share (₹)844.46
  • 52Wk L/H1872.95/ 2964.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed

Dr. Reddy's Laboratories Ltd Stock Price F & O Quotes

What's your view on Dr. Reddy's Laboratories for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.
Quarterly Results

Figures in Rs. Cr
Jun 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
3,762.40
0.41
3.06
0.00
8374.36
Other Operating Income
95.80
-66.08
11.66
0.00
115.06
Operating Profit
741.70
-9.43
-3.52
-95.02
2805.84
Other Income
430.10
416.33
753.37
0.00
430.10
EBITDA
1,171.80
29.88
43.04
-95.02
2805.84
Interest
29.80
21.63
52.82
0.00
122.00
Depreciation
289.00
0.63
3.70
0.00
457.13
Tax
192.80
27.85
262.41
-40.98
227.98
Net Profit
676.50
48.55
42.09
-94.19
1387.48
EPS (₹)
40.74
48.63
42.15
-9.29
40.74

Dr. Reddy's Laboratories Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
2574.15
1.29
2.59
-4.84
-2.39
4.49
-15.34
-10.91
751.50
1.74
2.66
-3.32
0.21
-16.81
-50.30
-41.65
218.00
-1.09
-0.34
-6.90
-12.90
-44.31
-42.93
-12.68
463.05
-0.61
-2.69
-12.98
-18.01
-29.62
-18.37
-9.63
1784.70
0.70
1.76
-1.68
6.11
-13.99
15.67
0.00
301.80
0.48
-1.74
-3.18
-1.93
0.89
30.68
0.00
599.70
0.24
-0.68
6.43
-10.78
-12.18
-24.08
44.93
1585.75
0.90
4.46
-4.86
-8.47
22.53
19.07
101.16
1680.55
1.26
1.54
0.41
8.27
-4.94
4.03
107.77
219.35
-2.14
1.43
-9.30
-14.08
-28.42
47.47
178.26
1498.85
0.42
-4.52
-8.52
-13.27
8.40
147.44
409.55
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Dr. Reddy's Laboratories Ltd Risk Return Comparison

with peersNew

Dr. Reddy's Laboratories Ltd
Financial Comparison

with peers
Management Efficiency
Dr. Reddy's Laboratories Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
13.90
8.96
-99.01
47.57
Return on Assets (%)
9.80
5.86
-27.48
26.25
Return on capital Employed (%)
8.21
7.36
-130.86
23.59
Fixed Assets Turnover (x)
0.88
0.97
0.00
2.79
Profitability and Growth
Gross Profit Margin (%)
13.22
-8.92
-980.00
34.42
Operating Profit Margin(%)
20.57
0.26
-896.19
37.94
Net Profit margin (%)
12.62
2.08
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.19
1.65
0.08
9.50
Current Ratio (x)
1.94
2.40
0.21
9.50
Cash ratio (x)
0.04
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.16
0.27
0.00
1.77
Coverage Ratios
Cash flows to long term debt (x)
1.12
3.73
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Dr. Reddy's Laboratories Ltd Share Holding as on 30-06-2019

CategoryNo. of sharesPercentage
Promoters44,458,52826.76
ForeignInstitutions51,051,41530.73
Others34,498,37220.77
NBanksMutualFunds14,241,4958.57
GeneralPublic12,842,5447.73
FinancialInstitutions8,624,3865.19
GDR397,1000.24

MF Ownership Of Dr. Reddy's Laboratories Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Aditya Birla SL Equity Direct-G
Portfolio as on 31-07-2019
Equity: Multi Cap
1519000
3.40%
3.66%
391.08
SBI ETF Nifty 50-D
Portfolio as on 31-07-2019
Equity: Large Cap
1474082
4.86%
0.69%
379.52
Franklin India Focused Equity Direct-G
Portfolio as on 31-07-2019
Equity: Multi Cap
1180008
74.82%
3.71%
303.80
Franklin India Bluechip Direct-G
Portfolio as on 31-07-2019
Equity: Large Cap
775000
287.50%
3.01%
199.53

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 42186.27 Crore) operating in Pharmaceuticals sector.

Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10466.70 Crore to Sales Value (98.50 % of Total Sales), Licence Fees which contributed Rs 55.90 Crore to Sales Value (0.52 % of Total Sales), Service Income which contributed Rs 50.30 Crore to Sales Value (0.47 % of Total Sales), Spent Chemicals which contributed Rs 35.60 Crore to Sales Value (0.33 % of Total Sales), Scrap which contributed Rs 16.10 Crore to Sales Value (0.15 % of Total Sales) and Other Operating Revenue which contributed Rs .90 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 3762.40 Crore, up .41 % from last quarter Sales of Rs 3747.20 Crore and up 3.06 % from last year same quarter Sales of Rs 3650.70 Crore Company has reported net profit after tax of Rs 660.20 Crore in latest quarter.

The company’s top management includes Dr.Bruce L A Carter, Mr.Allan Oberman, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Prasad R Menon, Mr.Sridar Iyengar, Ms.Kalpana Morparia, Ms.Shikha Sharma. Company has S R Batliboi & Associates LLP as its auditoRs As on 30-06-2019, the company has a total of 166,113,840 shares outstanding.

Close X
AlertWatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors